Home > > > > > Report Detail

COVID-19 Outbreak-Global Neurodegenerative Diseases Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Publisher Name :
Date: 18-Aug-2020
No. of pages: 114

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain.

Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don't reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson's, Alzheimer's, and Huntington's disease.

Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).

Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer's representing approximately 60-70% of dementia cases.

The Neurodegenerative Diseases market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Neurodegenerative Diseases industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Neurodegenerative Diseases market can be split based on product types, major applications, and important countries as follows:

Key players in the global Neurodegenerative Diseases market covered in Chapter 12:

Biogen Idec

Alector

Bayer

Asubio Pharmaceutical

Addex Pharmaceutical

Amarin

Yumanity Therapeutics

Pfizer

Boehringer Ingelheim

UCB

Merck

AstraZeneca

H.Lundbeck A/S

Novartis

Teva

Eisai

Bial

In Chapter 4 and 14.1, on the basis of types, the Neurodegenerative Diseases market from 2015 to 2025 is primarily split into:

NMDA

SSRIs

Dopamine Inhibitors

In Chapter 5 and 14.2, on the basis of applications, the Neurodegenerative Diseases market from 2015 to 2025 covers:

Parkinson's Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

Alzheimer's Disease

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

COVID-19 Outbreak-Global Neurodegenerative Diseases Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Table of Content

1 Neurodegenerative Diseases Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Neurodegenerative Diseases
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Neurodegenerative Diseases industry
1.4 Methodology of The Study
1.5 Research Data Source

2 Executive Summary
2.1 Market Overview
2.1.1 Global Neurodegenerative Diseases Market Size, 2015 - 2020
2.1.2 Global Neurodegenerative Diseases Market Size by Type, 2015 - 2020
2.1.3 Global Neurodegenerative Diseases Market Size by Application, 2015 - 2020
2.1.4 Global Neurodegenerative Diseases Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development

3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Neurodegenerative Diseases Analysis
3.2 Major Players of Neurodegenerative Diseases
3.3 Neurodegenerative Diseases Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Neurodegenerative Diseases
3.3.3 Labor Cost of Neurodegenerative Diseases
3.4 Market Distributors of Neurodegenerative Diseases
3.5 Major Downstream Buyers of Neurodegenerative Diseases Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 Global Neurodegenerative Diseases Market, by Type
4.1 Global Neurodegenerative Diseases Value and Market Share by Type (2015-2020)
4.2 Global Neurodegenerative Diseases Production and Market Share by Type (2015-2020)
4.3 Global Neurodegenerative Diseases Value and Growth Rate by Type (2015-2020)
4.3.1 Global Neurodegenerative Diseases Value and Growth Rate of NMDA
4.3.2 Global Neurodegenerative Diseases Value and Growth Rate of SSRIs
4.3.3 Global Neurodegenerative Diseases Value and Growth Rate of Dopamine Inhibitors
4.4 Global Neurodegenerative Diseases Price Analysis by Type (2015-2020)

5 Neurodegenerative Diseases Market, by Application
5.1 Downstream Market Overview
5.2 Global Neurodegenerative Diseases Consumption and Market Share by Application (2015-2020)
5.3 Global Neurodegenerative Diseases Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Neurodegenerative Diseases Consumption and Growth Rate of Parkinson's Disease (2015-2020)
5.3.2 Global Neurodegenerative Diseases Consumption and Growth Rate of Huntington Disease (2015-2020)
5.3.3 Global Neurodegenerative Diseases Consumption and Growth Rate of Amyotrophic Lateral Sclerosis (2015-2020)
5.3.4 Global Neurodegenerative Diseases Consumption and Growth Rate of Alzheimer's Disease (2015-2020)

6 Global Neurodegenerative Diseases Market Analysis by Regions
6.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions
6.1.1 Global Neurodegenerative Diseases Sales by Regions (2015-2020)
6.1.2 Global Neurodegenerative Diseases Revenue by Regions (2015-2020)
6.2 North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
6.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
6.6 South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7 North America Neurodegenerative Diseases Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
7.2.1 North America Neurodegenerative Diseases Sales by Countries (2015-2020)
7.2.2 North America Neurodegenerative Diseases Revenue by Countries (2015-2020)
7.3 United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
7.4 Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
7.5 Mexico Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8 Europe Neurodegenerative Diseases Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
8.2.1 Europe Neurodegenerative Diseases Sales by Countries (2015-2020)
8.2.2 Europe Neurodegenerative Diseases Revenue by Countries (2015-2020)
8.3 Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
8.4 UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
8.5 France Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
8.6 Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
8.7 Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
8.8 Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9 Asia Pacific Neurodegenerative Diseases Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)
9.2.2 Asia Pacific Neurodegenerative Diseases Revenue by Countries (2015-2020)
9.3 China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
9.4 Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
9.5 South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
9.6 India Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
9.8 Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10 Middle East and Africa Neurodegenerative Diseases Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2015-2020)
10.3 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
10.4 UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
10.5 Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
10.6 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
10.7 South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

11 South America Neurodegenerative Diseases Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
11.2.1 South America Neurodegenerative Diseases Sales by Countries (2015-2020)
11.2.2 South America Neurodegenerative Diseases Revenue by Countries (2015-2020)
11.3 Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
11.4 Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
11.5 Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
11.6 Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

12 Competitive Landscape
12.1 Biogen Idec
12.1.1 Biogen Idec Basic Information
12.1.2 Neurodegenerative Diseases Product Introduction
12.1.3 Biogen Idec Production, Value, Price, Gross Margin 2015-2020
12.2 Alector
12.2.1 Alector Basic Information
12.2.2 Neurodegenerative Diseases Product Introduction
12.2.3 Alector Production, Value, Price, Gross Margin 2015-2020
12.3 Bayer
12.3.1 Bayer Basic Information
12.3.2 Neurodegenerative Diseases Product Introduction
12.3.3 Bayer Production, Value, Price, Gross Margin 2015-2020
12.4 Asubio Pharmaceutical
12.4.1 Asubio Pharmaceutical Basic Information
12.4.2 Neurodegenerative Diseases Product Introduction
12.4.3 Asubio Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.5 Addex Pharmaceutical
12.5.1 Addex Pharmaceutical Basic Information
12.5.2 Neurodegenerative Diseases Product Introduction
12.5.3 Addex Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.6 Amarin
12.6.1 Amarin Basic Information
12.6.2 Neurodegenerative Diseases Product Introduction
12.6.3 Amarin Production, Value, Price, Gross Margin 2015-2020
12.7 Yumanity Therapeutics
12.7.1 Yumanity Therapeutics Basic Information
12.7.2 Neurodegenerative Diseases Product Introduction
12.7.3 Yumanity Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.8 Pfizer
12.8.1 Pfizer Basic Information
12.8.2 Neurodegenerative Diseases Product Introduction
12.8.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Basic Information
12.9.2 Neurodegenerative Diseases Product Introduction
12.9.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.10 UCB
12.10.1 UCB Basic Information
12.10.2 Neurodegenerative Diseases Product Introduction
12.10.3 UCB Production, Value, Price, Gross Margin 2015-2020
12.11 Merck
12.11.1 Merck Basic Information
12.11.2 Neurodegenerative Diseases Product Introduction
12.11.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.12 AstraZeneca
12.12.1 AstraZeneca Basic Information
12.12.2 Neurodegenerative Diseases Product Introduction
12.12.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.13 H.Lundbeck A/S
12.13.1 H.Lundbeck A/S Basic Information
12.13.2 Neurodegenerative Diseases Product Introduction
12.13.3 H.Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020
12.14 Novartis
12.14.1 Novartis Basic Information
12.14.2 Neurodegenerative Diseases Product Introduction
12.14.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.15 Teva
12.15.1 Teva Basic Information
12.15.2 Neurodegenerative Diseases Product Introduction
12.15.3 Teva Production, Value, Price, Gross Margin 2015-2020
12.16 Eisai
12.16.1 Eisai Basic Information
12.16.2 Neurodegenerative Diseases Product Introduction
12.16.3 Eisai Production, Value, Price, Gross Margin 2015-2020
12.17 Bial
12.17.1 Bial Basic Information
12.17.2 Neurodegenerative Diseases Product Introduction
12.17.3 Bial Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 Global Neurodegenerative Diseases Market Forecast
14.1 Global Neurodegenerative Diseases Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 NMDA Market Value and Volume Forecast (2020-2025)
14.1.2 SSRIs Market Value and Volume Forecast (2020-2025)
14.1.3 Dopamine Inhibitors Market Value and Volume Forecast (2020-2025)
14.2 Global Neurodegenerative Diseases Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Parkinson's Disease Market Value and Volume Forecast (2020-2025)
14.2.2 Huntington Disease Market Value and Volume Forecast (2020-2025)
14.2.3 Amyotrophic Lateral Sclerosis Market Value and Volume Forecast (2020-2025)
14.2.4 Alzheimer's Disease Market Value and Volume Forecast (2020-2025)
14.3 Neurodegenerative Diseases Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
?
List of Tables and Figures

Figure Product Picture of Neurodegenerative Diseases
Table Product Specification of Neurodegenerative Diseases
Table Neurodegenerative Diseases Key Market Segments
Table Key Players Neurodegenerative Diseases Covered
Figure Global Neurodegenerative Diseases Market Size, 2015 - 2025
Table Different Types of Neurodegenerative Diseases
Figure Global Neurodegenerative Diseases Value ($) Segment by Type from 2015-2020
Figure Global Neurodegenerative Diseases Market Share by Types in 2019
Table Different Applications of Neurodegenerative Diseases
Figure Global Neurodegenerative Diseases Value ($) Segment by Applications from 2015-2020
Figure Global Neurodegenerative Diseases Market Share by Applications in 2019
Figure Global Neurodegenerative Diseases Market Share by Regions in 2019
Figure North America Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020)
Figure Europe Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020)
Figure South America Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Neurodegenerative Diseases
Table Upstream Raw Material Suppliers of Neurodegenerative Diseases with Contact Information
Table Major Players Headquarters, and Service Area of Neurodegenerative Diseases
Figure Major Players Production Value Market Share of Neurodegenerative Diseases in 2019
Table Major Players Neurodegenerative Diseases Product Types in 2019
Figure Production Process of Neurodegenerative Diseases
Figure Manufacturing Cost Structure of Neurodegenerative Diseases
Figure Channel Status of Neurodegenerative Diseases
Table Major Distributors of Neurodegenerative Diseases with Contact Information
Table Major Downstream Buyers of Neurodegenerative Diseases with Contact Information
Table Global Neurodegenerative Diseases Value ($) by Type (2015-2020)
Table Global Neurodegenerative Diseases Value Share by Type (2015-2020)
Figure Global Neurodegenerative Diseases Value Share by Type (2015-2020)
Table Global Neurodegenerative Diseases Production by Type (2015-2020)
Table Global Neurodegenerative Diseases Production Share by Type (2015-2020)
Figure Global Neurodegenerative Diseases Production Share by Type (2015-2020)
Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of NMDA (2015-2020)
Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of SSRIs (2015-2020)
Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of Dopamine Inhibitors (2015-2020)
Figure Global Neurodegenerative Diseases Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Neurodegenerative Diseases Consumption by Application (2015-2020)
Table Global Neurodegenerative Diseases Consumption Market Share by Application (2015-2020)
Figure Global Neurodegenerative Diseases Consumption Market Share by Application (2015-2020)
Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Parkinson's Disease (2015-2020)
Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Huntington Disease (2015-2020)
Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Amyotrophic Lateral Sclerosis (2015-2020)
Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Alzheimer's Disease (2015-2020)
Figure Global Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Global Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table Global Neurodegenerative Diseases Sales by Regions (2015-2020)
Table Global Neurodegenerative Diseases Sales Market Share by Regions (2015-2020)
Table Global Neurodegenerative Diseases Revenue (M USD) by Regions (2015-2020)
Table Global Neurodegenerative Diseases Revenue Market Share by Regions (2015-2020)
Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2015
Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2019
Figure North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table North America Neurodegenerative Diseases Sales by Countries (2015-2020)
Table North America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)
Table North America Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020)
Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)
Figure United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Mexico Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table Europe Neurodegenerative Diseases Sales by Countries (2015-2020)
Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)
Table Europe Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020)
Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)
Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure France Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Italy Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Spain Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Russia Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)
Table Asia Pacific Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)
Figure China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure South Korea Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure India Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Southeast Asia Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Australia Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Middle East Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table Middle East Neurodegenerative Diseases Sales by Countries (2015-2020)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Egypt Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Nigeria Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure South Africa Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure South America Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020)
Table South America Neurodegenerative Diseases Sales by Countries (2015-2020)
Table South America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)
Table South America Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020)
Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)
Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)
Figure Columbia Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Chile Neurodegenerative Diseases Sales and Growth (2015-2020)
Figure Top 3 Market Share of Neurodegenerative Diseases Companies in 2019
Figure Top 6 Market Share of Neurodegenerative Diseases Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Biogen Idec Profile
Table Biogen Idec Product Introduction
Figure Biogen Idec Production and Growth Rate
Figure Biogen Idec Value ($) Market Share 2015-2020
Table Alector Profile
Table Alector Product Introduction
Figure Alector Production and Growth Rate
Figure Alector Value ($) Market Share 2015-2020
Table Bayer Profile
Table Bayer Product Introduction
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2015-2020
Table Asubio Pharmaceutical Profile
Table Asubio Pharmaceutical Product Introduction
Figure Asubio Pharmaceutical Production and Growth Rate
Figure Asubio Pharmaceutical Value ($) Market Share 2015-2020
Table Addex Pharmaceutical Profile
Table Addex Pharmaceutical Product Introduction
Figure Addex Pharmaceutical Production and Growth Rate
Figure Addex Pharmaceutical Value ($) Market Share 2015-2020
Table Amarin Profile
Table Amarin Product Introduction
Figure Amarin Production and Growth Rate
Figure Amarin Value ($) Market Share 2015-2020
Table Yumanity Therapeutics Profile
Table Yumanity Therapeutics Product Introduction
Figure Yumanity Therapeutics Production and Growth Rate
Figure Yumanity Therapeutics Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table UCB Profile
Table UCB Product Introduction
Figure UCB Production and Growth Rate
Figure UCB Value ($) Market Share 2015-2020
Table Merck Profile
Table Merck Product Introduction
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table H.Lundbeck A/S Profile
Table H.Lundbeck A/S Product Introduction
Figure H.Lundbeck A/S Production and Growth Rate
Figure H.Lundbeck A/S Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table Teva Profile
Table Teva Product Introduction
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2015-2020
Table Eisai Profile
Table Eisai Product Introduction
Figure Eisai Production and Growth Rate
Figure Eisai Value ($) Market Share 2015-2020
Table Bial Profile
Table Bial Product Introduction
Figure Bial Production and Growth Rate
Figure Bial Value ($) Market Share 2015-2020
Table Market Driving Factors of Neurodegenerative Diseases
Table Merger, Acquisition and New Investment
Table Global Neurodegenerative Diseases Market Value ($) Forecast, by Type
Table Global Neurodegenerative Diseases Market Volume Forecast, by Type
Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of NMDA (2020-2025)
Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of NMDA (2020-2025)
Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of SSRIs (2020-2025)
Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of SSRIs (2020-2025)
Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)
Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Parkinson's Disease (2020-2025)
Figure Market Volume and Growth Rate Forecast of Parkinson's Disease (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Huntington Disease (2020-2025)
Figure Market Volume and Growth Rate Forecast of Huntington Disease (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Amyotrophic Lateral Sclerosis (2020-2025)
Figure Market Volume and Growth Rate Forecast of Amyotrophic Lateral Sclerosis (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Alzheimer's Disease (2020-2025)
Figure Market Volume and Growth Rate Forecast of Alzheimer's Disease (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
  • Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110
    Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
  • Global Epilepsy Therapeutics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......
  • Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109
    Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
  • Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
  • Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
  • 2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......
  • Global Gabapentin Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112
    Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs